These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34996756)

  • 1. Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial.
    INSPIRATION-S Investigators
    BMJ; 2022 Jan; 376():e068407. PubMed ID: 34996756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
    ; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
    JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.
    Bikdeli B; Talasaz AH; Rashidi F; Sharif-Kashani B; Farrokhpour M; Bakhshandeh H; Sezavar H; Dabbagh A; Beigmohammadi MT; Payandemehr P; Yadollahzadeh M; Riahi T; Khalili H; Jamalkhani S; Rezaeifar P; Abedini A; Lookzadeh S; Shahmirzaei S; Tahamtan O; Matin S; Amin A; Parhizgar SE; Jimenez D; Gupta A; Madhavan MV; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Mohebbi B; Piazza G; Kirtane AJ; Lip GYH; Krumholz HM; Goldhaber SZ; Sadeghipour P
    Thromb Res; 2020 Dec; 196():382-394. PubMed ID: 32992075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial.
    Talasaz AH; Sadeghipour P; Bakhshandeh H; Sharif-Kashani B; Rashidi F; Beigmohammadi MT; Moghadam KG; Rezaian S; Dabbagh A; Sezavar SH; Farrokhpour M; Abedini A; Aliannejad R; Riahi T; Yadollahzadeh M; Lookzadeh S; Rezaeifar P; Matin S; Tahamtan O; Mohammadi K; Zoghi E; Rahmani H; Hosseini SH; Mousavian SM; Abri H; Sadeghipour P; Baghizadeh E; Rafiee F; Jamalkhani S; Amin A; Mohebbi B; Parhizgar SE; Soleimanzadeh M; Aghakouchakzadeh M; Eslami V; Payandemehr P; Khalili H; Talakoob H; Tojari T; Shafaghi S; Tabrizi S; Kakavand H; Kashefizadeh A; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Ansarin K; Maleki M; Sadeghian S; Barco S; Siegerink B; Spatz ES; Piazza G; Kirtane AJ; Tassell BWV; Lip GYH; Klok FA; Goldhaber SZ; Stone GW; Krumholz HM; Bikdeli B
    Thromb Haemost; 2023 Jul; 123(7):723-733. PubMed ID: 36944357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial.
    Bikdeli B; Talasaz AH; Rashidi F; Bakhshandeh H; Rafiee F; Rezaeifar P; Baghizadeh E; Matin S; Jamalkhani S; Tahamtan O; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Khalili H; Yadollahzadeh M; Riahi T; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Amin A; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Dobesh PP; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Sadeghipour P
    Thromb Haemost; 2022 Jan; 122(1):131-141. PubMed ID: 33865239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial.
    Sholzberg M; Tang GH; Rahhal H; AlHamzah M; Kreuziger LB; Áinle FN; Alomran F; Alayed K; Alsheef M; AlSumait F; Pompilio CE; Sperlich C; Tangri S; Tang T; Jaksa P; Suryanarayan D; Almarshoodi M; Castellucci LA; James PD; Lillicrap D; Carrier M; Beckett A; Colovos C; Jayakar J; Arsenault MP; Wu C; Doyon K; Andreou ER; Dounaevskaia V; Tseng EK; Lim G; Fralick M; Middeldorp S; Lee AYY; Zuo F; da Costa BR; Thorpe KE; Negri EM; Cushman M; Jüni P;
    BMJ; 2021 Oct; 375():n2400. PubMed ID: 34649864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
    Spyropoulos AC; Goldin M; Giannis D; Diab W; Wang J; Khanijo S; Mignatti A; Gianos E; Cohen M; Sharifova G; Lund JM; Tafur A; Lewis PA; Cohoon KP; Rahman H; Sison CP; Lesser ML; Ochani K; Agrawal N; Hsia J; Anderson VE; Bonaca M; Halperin JL; Weitz JI;
    JAMA Intern Med; 2021 Dec; 181(12):1612-1620. PubMed ID: 34617959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial.
    Ely EW; Ramanan AV; Kartman CE; de Bono S; Liao R; Piruzeli MLB; Goldman JD; Saraiva JFK; Chakladar S; Marconi VC;
    Lancet Respir Med; 2022 Apr; 10(4):327-336. PubMed ID: 35123660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT.
    Bohula EA; Berg DD; Lopes MS; Connors JM; Babar I; Barnett CF; Chaudhry SP; Chopra A; Ginete W; Ieong MH; Katz JN; Kim EY; Kuder JF; Mazza E; McLean D; Mosier JM; Moskowitz A; Murphy SA; O'Donoghue ML; Park JG; Prasad R; Ruff CT; Shahrour MN; Sinha SS; Wiviott SD; Van Diepen S; Zainea M; Baird-Zars V; Sabatine MS; Morrow DA;
    Circulation; 2022 Nov; 146(18):1344-1356. PubMed ID: 36036760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization.
    Wang TY; Wahed AS; Morris A; Kreuziger LB; Quigley JG; Lamas GA; Weissman AJ; Lopez-Sendon J; Knudson MM; Siegal DM; Kasthuri RS; Alexander AJ; Wahid L; Atassi B; Miller PJ; Lawson JW; Patel B; Krishnan JA; Shapiro NL; Martin DE; Kindzelski AL; Leifer ES; Joo J; Lyu L; Pennella A; Everett BM; Geraci MW; Anstrom KJ; Ortel TL;
    Ann Intern Med; 2023 Apr; 176(4):515-523. PubMed ID: 36940444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety profile of enhanced thromboprophylaxis strategies for critically ill COVID-19 patients during the first wave of the pandemic: observational report from 28 European intensive care units.
    Lavinio A; Ercole A; Battaglini D; Magnoni S; Badenes R; Taccone FS; Helbok R; Thomas W; Pelosi P; Robba C;
    Crit Care; 2021 Apr; 25(1):155. PubMed ID: 33888132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis.
    Kitas GD; Nightingale P; Armitage J; Sattar N; Belch JJF; Symmons DPM;
    Arthritis Rheumatol; 2019 Sep; 71(9):1437-1449. PubMed ID: 30983166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.
    Lopes RD; de Barros E Silva PGM; Furtado RHM; Macedo AVS; Bronhara B; Damiani LP; Barbosa LM; de Aveiro Morata J; Ramacciotti E; de Aquino Martins P; de Oliveira AL; Nunes VS; Ritt LEF; Rocha AT; Tramujas L; Santos SV; Diaz DRA; Viana LS; Melro LMG; de Alcântara Chaud MS; Figueiredo EL; Neuenschwander FC; Dracoulakis MDA; Lima RGSD; de Souza Dantas VC; Fernandes ACS; Gebara OCE; Hernandes ME; Queiroz DAR; Veiga VC; Canesin MF; de Faria LM; Feitosa-Filho GS; Gazzana MB; Liporace IL; de Oliveira Twardowsky A; Maia LN; Machado FR; de Matos Soeiro A; Conceição-Souza GE; Armaganijan L; Guimarães PO; Rosa RG; Azevedo LCP; Alexander JH; Avezum A; Cavalcanti AB; Berwanger O;
    Lancet; 2021 Jun; 397(10291):2253-2263. PubMed ID: 34097856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Add-On Prostaglandin E
    Buchtele N; Schörgenhofer C; Schwameis M; Jilma B; Schellongowski P; Herkner H; Riss K; Schmid M; Hermann A; Robak O; Nagler B; Traby L; Bojic A; Staudinger T
    Am J Respir Crit Care Med; 2022 Jul; 206(2):170-177. PubMed ID: 35426776
    [No Abstract]   [Full Text] [Related]  

  • 15. Initial therapeutic anticoagulation with rivaroxaban compared to prophylactic therapy with heparins in moderate to severe COVID-19: results of the COVID-PREVENT randomized controlled trial.
    Rauch-Kröhnert U; Puccini M; Placzek M; Beyer-Westendorf J; Jakobs K; Friebel J; Hein S; Seidel M; Pieske B; Massberg S; Witzenrath M; Zeiher A; Friede T; Anker SD; Landmesser U
    Clin Res Cardiol; 2023 Nov; 112(11):1620-1638. PubMed ID: 37407731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
    Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD
    JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate- or Delayed-Intensive Statin in Acute Cerebral Ischemia: The INSPIRES Randomized Clinical Trial.
    Gao Y; Jiang L; Pan Y; Chen W; Jing J; Wang C; Johnston SC; Amarenco P; Bath PM; Yang Y; Wang T; Han S; Meng X; Lin J; Zhao X; Liu L; Zhao J; Li Y; Zang Y; Zhang S; Yang H; Yang J; Wang Y; Li D; Wang Y; Liu D; Kang G; Wang Y; Wang Y;
    JAMA Neurol; 2024 Jul; 81(7):741-751. PubMed ID: 38805216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: A multi-center, open-label, randomized controlled trial.
    Perepu US; Chambers I; Wahab A; Ten Eyck P; Wu C; Dayal S; Sutamtewagul G; Bailey SR; Rosenstein LJ; Lentz SR
    J Thromb Haemost; 2021 Sep; 19(9):2225-2234. PubMed ID: 34236768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Huang DQ; Ajmera V; Tomaszewski C; LaFree A; Bettencourt R; Thompson WK; Smith DM; Malhotra A; Mehta RL; Tolia V; Yin J; Insel PA; Leachman S; Jung J; Collier S; Richards L; Woods K; Amangurbanova M; Bhatt A; Zhang X; Penciu OM; Zarich S; Retta T; Harkins MS; Teixeira JP; Chinnock B; Utay NS; Lake JE; Loomba R
    Adv Ther; 2023 Nov; 40(11):4805-4816. PubMed ID: 37615850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19.
    Al-Samkari H; Gupta S; Leaf RK; Wang W; Rosovsky RP; Brenner SK; Hayek SS; Berlin H; Kapoor R; Shaefi S; Melamed ML; Sutherland A; Radbel J; Green A; Garibaldi BT; Srivastava A; Leonberg-Yoo A; Shehata AM; Flythe JE; Rashidi A; Goyal N; Chan L; Mathews KS; Hedayati SS; Dy R; Toth-Manikowski SM; Zhang J; Mallappallil M; Redfern RE; Bansal AD; Short SAP; Vangel MG; Admon AJ; Semler MW; Bauer KA; Hernán MA; Leaf DE;
    Ann Intern Med; 2021 May; 174(5):622-632. PubMed ID: 33493012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.